EV/EBITDA
-16.53
+0.08+0.48%
Thu, 06 Mar 2025 21:01:13 GMT
Summary
- As of March 7, 2025, MLTX EV/EBITDA is -16.53, with a rise of +0.08 (+0.48%) during the most recent trading day.
- Over the past year, MLTX EV/EBITDA has increased by +27.74 (+62.66%).
- MLTX EV/EBITDA is now -550.79% below its all-time high of -2.54.
Performance
MLTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
MLTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +0.5% | -0.5% | -0.4% |
| 1 m1 month | +16.4% | -16.4% | -15.5% |
| 3 m3 months | +41.3% | -23.3% | -26.7% |
| 6 m6 months | +49.3% | -8.3% | -13.5% |
| ytdytd | +27.6% | -27.6% | -26.5% |
| 1 y1 year | +62.7% | -2.2% | -11.9% |
| 5 y5 years | - | - | - |
MLTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -19.77 | +16.4% | |
| 3 m | 3-month | -16.53 | at high | -29.31 | +43.6% |
| 6 m | 6-month | -16.53 | at high | -40.25 | +58.9% |
| 1 y | 1-year | -16.53 | at high | -52.59 | +68.6% |
| 3 y | 3-year | -2.54 | -550.8% | -63.12 | +73.8% |
| 5 y | 5-year | -2.54 | -550.8% | -63.12 | +73.8% |
| alltime | all time | -2.54 | -550.8% | -63.12 | +73.8% |
MoonLake Immunotherapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -16.53(-27.6%) |
| 2024 | -22.84(-61.4%) |
| Date | Value |
|---|---|
| 2023 | -59.22(+895.3%) |
| 2022 | -5.95 |
FAQ
- What is MoonLake Immunotherapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for MoonLake Immunotherapeutics?
- What is MLTX EV/EBITDA year-to-date change?
- What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?
What is MoonLake Immunotherapeutics EV/EBITDA?
The current EV/EBITDA of MLTX is -16.53
What is the all time high EV/EBITDA for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high EV/EBITDA is -2.54
What is MLTX EV/EBITDA year-to-date change?
MoonLake Immunotherapeutics EV/EBITDA has changed by +6.31 (+27.63%) since the beginning of the year
What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?
Over the past year, MLTX EV/EBITDA has changed by +27.74 (+62.66%)